Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections : a prospective multicentre study (WISS Study) by Sartelli, Massimo et al.
RESEARCH ARTICLE Open Access
Global validation of the WSES Sepsis
Severity Score for patients with
complicated intra-abdominal infections: a
prospective multicentre study (WISS Study)
Massimo Sartelli1*, Fikri M. Abu-Zidan2, Fausto Catena3, Ewen A. Griffiths4, Salomone Di Saverio5, Raul Coimbra6,
Carlos A. Ordoñez7, Ari Leppaniemi8, Gustavo P. Fraga9, Federico Coccolini10, Ferdinando Agresta11,
Asrhaf Abbas12, Saleh Abdel Kader13, John Agboola14, Adamu Amhed15, Adesina Ajibade16, Seckin Akkucuk17,
Bandar Alharthi18, Dimitrios Anyfantakis19, Goran Augustin20, Gianluca Baiocchi21, Miklosh Bala22,
Oussama Baraket23, Savas Bayrak24, Giovanni Bellanova25, Marcelo A. Beltràn26, Roberto Bini27, Matthew Boal4,
Andrey V. Borodach28, Konstantinos Bouliaris29, Frederic Branger30, Daniele Brunelli31, Marco Catani32,
Asri Che Jusoh33, Alain Chichom-Mefire34, Gianfranco Cocorullo35, Elif Colak36, David Costa37, Silvia Costa38,
Yunfeng Cui39, Geanina Loredana Curca40, Terry Curry6, Koray Das41, Samir Delibegovic42, Zaza Demetrashvili43,
Isidoro Di Carlo44, Nadezda Drozdova45, Tamer El Zalabany46, Mushira Abdulaziz Enani47, Mario Faro48,
Mahir Gachabayov49, Teresa Giménez Maurel50, Georgios Gkiokas51, Carlos Augusto Gomes52,
Ricardo Alessandro Teixeira Gonsaga53, Gianluca Guercioni54, Ali Guner55, Sanjay Gupta56, Sandra Gutierrez57,
Martin Hutan58, Orestis Ioannidis59, Arda Isik60, Yoshimitsu Izawa61, Sumita A. Jain62, Mantas Jokubauskas63,
Aleksandar Karamarkovic64, Saila Kauhanen65, Robin Kaushik56, Jakub Kenig66, Vladimir Khokha67, Jae Il Kim68,
Victor Kong69, Renol Koshy44, Avidyl Krasniqi70, Ashok Kshirsagar71, Zygimantas Kuliesius72,
Konstantinos Lasithiotakis73, Pedro Leão74, Jae Gil Lee75, Miguel Leon76, Aintzane Lizarazu Pérez77,
Varut Lohsiriwat78, Eudaldo López-Tomassetti Fernandez79, Eftychios Lostoridis80, Raghuveer Mn81, Piotr Major82,
Athanasios Marinis83, Daniele Marrelli84, Aleix Martinez-Perez85, Sanjay Marwah86, Michael McFarlane87,
Renato Bessa Melo88, Cristian Mesina89, Nick Michalopoulos90, Radu Moldovanu91, Ouadii Mouaqit92,
Akutu Munyika93, Ionut Negoi94, Ioannis Nikolopoulos95, Gabriela Elisa Nita10, Iyiade Olaoye96, Abdelkarim Omari97,
Paola Rodríguez Ossa7, Zeynep Ozkan98, Ramakrishnapillai Padmakumar99, Francesco Pata100,
Gerson Alves Pereira Junior101, Jorge Pereira102, Tadeja Pintar103, Konstantinos Pouggouras80, Vinod Prabhu104,
Stefano Rausei105, Miran Rems106, Daniel Rios-Cruz107, Boris Sakakushev108, Maria Luisa Sánchez de Molina109,
Charampolos Seretis110, Vishal Shelat111, Romeo Lages Simões9, Giovanni Sinibaldi112, Matej Skrovina113,
Dmitry Smirnov114, Charalampos Spyropoulos115, Jaan Tepp116, Tugan Tezcaner117, Matti Tolonen8, Myftar Torba118,
Jan Ulrych119, Mustafa Yener Uzunoglu120, David van Dellen121, Gabrielle H. van Ramshorst122, Giorgio Vasquez123,
Aurélien Venara30, Andras Vereczkei124, Nereo Vettoretto125, Nutu Vlad126, Sanjay Kumar Yadav127,
Tonguç Utku Yilmaz128, Kuo-Ching Yuan129, Sanoop Koshy Zachariah130, Maurice Zida131, Justas Zilinskas63
and Luca Ansaloni10
* Correspondence: massimosartelli@gmail.com
1Department of Surgery, Macerata Hospital, Macerata, Italy
Full list of author information is available at the end of the article
© 2015 Sartelli et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sartelli et al. World Journal of Emergency Surgery  (2015) 10:61 
DOI 10.1186/s13017-015-0055-0
Abstract
Background: To validate a new practical Sepsis Severity Score for patients with complicated intra-abdominal
infections (cIAIs) including the clinical conditions at the admission (severe sepsis/septic shock), the origin of the
cIAIs, the delay in source control, the setting of acquisition and any risk factors such as age and immunosuppression.
Methods: The WISS study (WSES cIAIs Score Study) is a multicenter observational study underwent in 132 medical
institutions worldwide during a four-month study period (October 2014-February 2015). Four thousand five hundred
thirty-three patients with a mean age of 51.2 years (range 18–99) were enrolled in the WISS study.
Results: Univariate analysis has shown that all factors that were previously included in the WSES Sepsis Severity Score
were highly statistically significant between those who died and those who survived (p < 0.0001). The multivariate
logistic regression model was highly significant (p < 0.0001, R2 = 0.54) and showed that all these factors were
independent in predicting mortality of sepsis. Receiver Operator Curve has shown that the WSES Severity Sepsis
Score had an excellent prediction for mortality. A score above 5.5 was the best predictor of mortality having a
sensitivity of 89.2 %, a specificity of 83.5 % and a positive likelihood ratio of 5.4.
Conclusions: WSES Sepsis Severity Score for patients with complicated Intra-abdominal infections can be used on
global level. It has shown high sensitivity, specificity, and likelihood ratio that may help us in making clinical decisions.
Keywords: Intra-abdominal, Infections, Sepsis, Septic shock
Background
Intra-abdominal infections (IAIs) include several differ-
ent pathological conditions [1] and are usually classi-
fied into uncomplicated and complicated. In
complicated IAIs (cIAIs), the infectious process extends
beyond the organ, and causes either localized periton-
itis or diffuse peritonitis. The treatment of patients with
complicated intra-abdominal infections involves both
source control and antibiotic therapy. Complicated IAIs
are an important cause of morbidity and may be associ-
ated with poor prognosis. However the term “compli-
cated intra-abdominal infections” describes a wide
heterogeneity of patient populations, making it difficult
to suggest a general treatment regimen and stressing
the need of an individualized approach to decision
making.
Early prognostic evaluation of complicated intra-
abdominal infections is crucial to assess the severity
and decide the aggressiveness of treatment. Many fac-
tors influencing the prognosis of patients with cIAIs
have been described, including advanced age, poor nu-
trition, pre-existing diseases, immunosuppression, ex-
tended peritonitis, occurrence of septic shock, poor
source control, organ failures, prolonged hospitalization
before therapy, and infection with nosocomial patho-
gens [2–10].
Recently the World Society of Emergency Surgery
(WSES) designed a global prospective observational
study (CIAOW Study) [11, 12]. All the risk factors for
occurrence of death during hospitalization were evalu-
ated and then discussed with an international panel of
experts. The most significant variables, adjusted to clin-
ical criteria, were used to create a severity score for pa-
tients with cIAIs including the clinical conditions at
admission (severe sepsis/septic shock), the origin of the
cIAIs, the delay in source control, the setting of acquisi-
tion and any risk factors such as age and immunosup-
pression (Appendix).
There may be different causes of sepsis, health care
standards, and differences in underlying health status,
economical differences that make prediction of sepsis on
global level difficult. The WSES addressed this issue in
the present study which aims to validate a previous score
on a global level.
Methods
Ethical statement
The study met the standards outlined in the Declaration
of Helsinki and Good Epidemiological Practices. This
study did not change or modify the laboratory or clinical
practices of each centre and differences of practices were
kept as they are. The data collection was anonymous
and identifiable patient information was not submitted.
Individual researchers were responsible for complying
with local ethical standards and hospital registration of
the study.
Study population
This multicenter observational study was run in 132
medical institutions from 54 countries worldwide dur-
ing a four-month period (October 2014-February
2015). Inclusion criteria were patients older than
18 years with complicated intra-abdominal sepsis
(cIAIs) who had surgical management or interventional
radiological drainage. cIAIs was defined as an infectious
process that proceeded beyond the organ, and caused
either localized peritonitis/abscess or diffuse peritonitis
[13]. Patients who were younger than 18 years, or those
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who had pancreatitis, or primary peritonitis were ex-
cluded from the study. Severe sepsis was defined as
sepsis-induced tissue hypoperfusion or organ dysfunc-
tion (any of the following thought to be due to the in-
fection): hypotension (<90/60 or MAP < 65), lactate above
upper limits laboratory normal, Urine output < 0.5 mL/kg/
h for more than 2 h despite adequate fluid resuscitation,
Creatinine > 2.0 mg/dL (176.8 μmol/L), Bilirubin > 2 mg/dL
(34.2 μmol/L), Platelet count < 100,000 μL, Coagulopathy
(international normalized ratio > 1.5), Acute lung injury
with Pao2/Fio2 < 250 in the absence of pneumonia as infec-
tion source. Septic shock was defined as severe sepsis asso-
ciated with refractory hypotension (BP < 90/60) despite
adequate fluid resuscitation [14].
WSES Sepsis Severity Score for patients with com-
plicated Intra-abdominal infections is shown in
Appendix.
Data monitoring and collection
The study was monitored by the coordination center,
which investigated and verified missing or unclear data
submitted to the central database. This study was per-
formed under the direct supervision of the Board of
Directors of WSES. In each centre, the coordinator col-
lected and compiled data in an online case report sys-
tem. Data were entered directly through a web-based
computerized database. Data were entered either by a
drop menu for categorical data like the source of infec-
tion or numbers for continuous variables such as age.
Data collected included demographic data of the patient
and disease characteristics, demographical data, type of
infection (community- or healthcare-acquired), severity
criteria and origin of infection and surgical procedures
performed.
Statistical analysis
Sepsis status was coded as ordinal data for testing the lo-
gistic regression (not for scoring) as follows: no sepsis = 0,
sepsis = 2, severe sepsis = 3, septic shock = 4). The
source of sepsis was analysed as categorical data in the
logistic regression, and the age as continuous data,
while healthcare associated infection, delay in manage-
ment, and immunosuppression as binomial data. The
variables used in this scoring system in the patients
who survived and those who died were compared using
univariate analysis. This included Fisher’s exact test or
Pearson Chi-Square as appropriate for categorical data
and Mann–Whitney U-test for continuous or ordinal
data. Significant factors were then entered into a direct
logistic regression model. A p value of ≤ 0.05 was con-
sidered significant. Data were analyzed with PASW
Statistics 21, SPSS Inc, USA.
Results
Four thousand six hundred fifty-two cases were collected
in the online case report system. One hundred twenty-
nine cases did not meet the inclusion criteria. Four
thousand five hundred thirty-three patients with a mean
age of 51.2 years (range 18–99) were enrolled in the
WISS study. One thousand nine hundred thirty-five pa-
tients (42.7 %) were women and 2598 (57.3 %) were
men.
Among these patients, 3966 (87.5 %) were affected by
community-acquired IAIs while the remaining 567
(12.5 %) suffered from healthcare-associated infections.
One thousand six hundred twenty-seven patients
(35.9 %) were affected by generalized peritonitis while
2906 (64.1 %) suffered from localized peritonitis or ab-
scesses. Seven hundred ninety-one patients (17.4 %)
were admitted in critical condition (severe sepsis/septic
shock). The various sources of infection are outlined in
Table 1. The most frequent source of infection was acute
appendicitis; 1553 cases (34.2 %) involved complicated
appendicitis.
The overall mortality rate was 9.2 % (416/4533).
Table 2 shows the univariate analysis comparing pa-
tients with complicated intra-abdominal infection who
survived and those who died. The analysis shows that
all factors included in the Sepsis Severity Score were
highly significantly different between those who died
and those who survived (p < 0.0001 in all variables).
Accordingly all factors were entered into a direct lo-
gistic regression model (Table 3). The direct logistic
regression model was highly significant (p < 0.0001,
R2 = 0.54) and showed that all factors included in the
Sepsis Severity Score were significant independent
Table 1 Source of infection in 4553 patients from 132 hospitals
worldwide (15 October 2014–15 February 2015)
Source of infection Number (%)
Appendicitis 1553 (34.2 %)
Cholecystitis 837 (18.5 %)
Post-operative 387 (8.5 %)
Colonic non diverticular perforation 269 (5.9 %)
Gastro-duodenal perforations 498 (11 %)
Diverticulitis 234 (5.2 %)
Small bowel perforation 243 (5.4 %)
Others 348 (7.7 %)
PID 50 (1.1 %)
Post traumatic perforation 114 (2.5 %)
Missing
Total 4553 (100 %)
PID pelvic inflammatory disease
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Table 2 Univariate analysis of patients with complicated intra-abdominal infection comparing patients who survived (n = 4117) and
patient who died (n = 416)
Variable Survided (%) n = 4117 Died (%) n = 416 p value
Sepsis status <0.0001
No sepsis 1914 (46.5 %) 23 (5.5 %)
Sepsis 1725 (41.9 %) 80 (19.2 %)
Severe sepsis 404 (9.8 %) 157 (37.7 %)
Septic shock 74 (1.8 %) 156 (37.5 %)
Healthcare associated infection 433 (10.5 %) 134 (32.2 %) <0.0001
Source of infection <0.0001
Appendicitis 1536 (37.3 %) 17 (4.1 %)
Cholecystitis 809 (19.7 %) 28 (6.7 %)
Colonic non diverticular perforation 204 (5 %) 65 (15.6 %)
Diverticulitis 203 (4.9 %) 31 (7.5 %)
Gastro-duodenal perforation 431 (10.5 %) 67 (16.2 %)
PID 50 (1.2 %) 0 (0)
Postoperative 415 (10.1 %) 86 (20.7 %)
Small bowel perforation 174 (4.2 %) 69 (16.6 %)
Post-traumatic 104 (2.5 %) 10 (2.4 %)
Others 259 (6.3 %) 53 (12.7 %)
Delay in source control 2015 (48.9 %) 341 (82 %) <0.0001
Median age years (range) 48 (18–97) 79 (18–99) <0.0001
Immunosuppresion 292 (7.1) 120 (28.8 %) <0.0001
Sepsis severity score 3 (0–17) 10 (0–17) <0.0001
Data presented as median range or number percentage as appropriate
PID pelvic inflammatory disease
p value = Fisher’s exact test, Pearson Chi-Square, or Mann Whitney U test as appropriate
Table 3 Direct logistic regression model with factors affecting mortality of patients complicated intra-abdominal infection, global
study of 132 centres, (n = 4553)
Score variable B S.E. Wald test P value OR OR 95 % C.I.
Lower Upper
Sepsis status 1.57 0.08 365.59 <0.0001 4.81 4.09 5.65
Setting of infection acquisition 0.6 0.18 10.49 0.001 1.81 1.27 2.6
Source of infectiona 59.38 <0.0001
Colonic non-diverticulical perforation −0.26 0.27 0.97 0.33 0.77 0.46 1.3
Diverticulitis diffuse peritonitis −0.26 0.34 0.51 0.48 0.78 0.40 1.54
Postoperative diffuse peritonitis −0.005 0.29 0 0.99 1.00 0.56 1.76
Remaining sources −1.2 0.21 32.47 <0.0001 0.30 0.20 0.46
Delay in management 1.47 0.17 78.53 <0.0001 4.33 3.13 5.99
Age 0.04 0.004 103.58 <0.0001 1.04 1.04 1.05
Immunosuppression 1.24 0.17 55.79 <0.0001 3.46 2.5 4.79
Constant −7.52 0.41 342.24 <0.0001 0.001
OR odds ratio
aCompared with small bowel perforation
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predictors of mortality. Accordingly the ability of the
score to predict mortality was tested by a direct logis-
tic regression which is shown in Table 4. Again, this
model using only the sepsis severity score was highly
significant (p < 0.0001, R2 = 0.5). The odds of death in-
creased by 0.78 by an increase on one score which is
remarkable.
Figure 1 shows that WSES Sepsis Severity Score
had a very good ability of distinguishing those who
survived from those who died. The overall mortality
rate was 9.2 % (416/4533). This was 0.63 % for those
who had a score of 0–3, 6.3 % for those who had a
score of 4–6, and 41.7 % for those who had a score
of ≥ 7. The receiver operating characteristic curve
showed that the best cutoff point for predicting mor-
tality was a Sepsis Severity Score. 5.5 was the best
predictor of mortality having a sensitivity of 89.2 %,
a specificity of 83.5 % and a positive likelihood ratio
of 5.4 (Fig. 2).
Discussion
Complicated intra-abdominal infections remain an
important source of patient morbidity and may be
frequently associated with poor clinical prognosis.
Treatment of patients with cIAIs, has been usually
described to achieve satisfactory results if adequate
management is established [15]. However, results
from published clinical trials may not be representa-
tive of the true morbidity and mortality rates of such
severe infections. First of all, patients who have per-
forated appendicitis are usually over-represented in
clinical trials. Furthermore patients with intra-
abdominal infection enrolled in clinical trials have
often an increased likelihood of cure and survival. In
fact the trial eligibility criteria usually restrict the in-
clusion of patients with co-morbid diseases that
would increase the death rate of patients with intra-
abdominal infections [16]. In the WISS study we en-
rolled all the patients older than 18 years old with
complicated intra-abdominal infections in the study-
period and the overall mortality rate was 9.2 % (416/
4533). Stratification of the patient’s risk is essential
in order to optimize the treatment plan. Patients
with intra-abdominal infections are generally classi-
fied into low risk and high risk. “High risk” is gener-
ally intended to describe patients with a high risk
for treatment failure and mortality. In high risk pa-
tients the increased mortality associated with in-
appropriate management cannot be reversed by
subsequent modifications. Therefore early prognostic
Table 4 Direct logistic regression model showing the ability of
WSES Sepsis Severity Score in predicting mortality of patients
complicated intra-abdominal infection, global study of 132
centres, (n = 4553)
Variable B S.E. Wald P value OR OR 95 % C.I.
Lower Upper
WSESSCORE 0.58 0.02 639.59 <0.0001 1.784 1.706 1.866
Constant −5.79 0.19 958.74 <0.0001 .003
OR odds ratio
Fig. 1 Distribution of the percentile WSES Sepsis Severity Score of complicated intra-abdominal infection patients for those who survived (solid
line) (n = 4117) and those who died (interrupted line) (n = 416)
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evaluation of complicated intra-abdominal infections
is important to assess the severity and decide the ag-
gressiveness of treatment.
Scoring systems can be roughly divided into two
groups: disease-independent scores for evaluation of
serious patients requiring care in the intensive care unit
(ICU) such as APACHE II and Simplified Acute Physi-
ology Score (SAPS II) and peritonitis-specific scores
such as Mannheim Peritonitis Index (MPI) [17].
Although considered a good marker, APACHE II value
in peritonitis has been questioned because of the diffi-
culty of the APACHE II to evaluate interventions despite
the fact that interventions might significantly alter many
of the physiological variables. Moreover it requires
appropriate software to be calculated [18].
The MPI is specific for peritonitis and easy to calculate.
MPI was designed by Wacha and Linder in 1983 [19]. It
was based on a retrospective analysis of data from 1253
patients with peritonitis. Among 20 possible risk factors,
only 8 proved to be of prognostic relevance and were en-
tered into the Mannheim Peritonitis Index, classified ac-
cording to their predictive power. After 30 years,
identifying a new clinical score to assess the severity the
cIAIS would be clinically relevant in order to modulate
the aggressiveness of treatment according the type of in-
fection and the clinical characteristics of the patients.
WSES Sepsis Severity Score is a new practical clin-
ical severity score for patients with complicated intra-
abdominal infections. It is specific for cIAIs and easy
to calculate, even during surgery. It may be relevant in
order to modulate the aggressiveness of treatment par-
ticularly in higher risk patients.
The score is illustrated in Appendix. The statistical
analysis shows that the sepsis severity score has a
very good ability of distinguishing those who sur-
vived from those who died. The overall mortality
was 0.63 % for those who had a score of 0–3, 6.3 %
for those who had a score of 4–6, 41.7 % for those
who had a score of ≥ 7. In patients who had a score
of ≥ 9 the mortality rate was 55.5 %, those who had
a score of ≥ 11 the mortality rate was 68.2 % and
those who had a score ≥ 13 the mortality rate was
80.9 %.
Conclusions
Given the sweeping geographical distribution of the par-
ticipating medical centers, WSES Sepsis Severity Score
for patients with complicated Intra-abdominal infections
can be used on global level. It has shown high sensitivity,
specificity, and likelihood ratio that may help us in mak-
ing clinical decisions.
Fig. 2 Receiver operating characteristic curve for the best WSES Sepsis Severity Score that predicted mortality in patients having complicated
intra-abdominal infection, global study of 132 centres, (n = 4553)
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Intra-abdominal infections (Range: 0–18)
Clinical condition at the admission
• Severe sepsis (acute organ dysfunction) at the
admission
3 score
• Septic shock (acute circulatory failure characterized
by persistent arterial hypotension. It always requires
vasopressor agents) at the admission
5 score
Setting of acquisition
• Healthcare associated infection 2 score
Origin of the IAIs
• Colonic non-diverticular perforation peritonitis 2 score
• Small bowel perforation peritonitis 3 score
• Diverticular diffuse peritonitis 2 score
• Post-operative diffuse peritonitis 2 score
Delay in source control
• Delayed initial intervention [Preoperative duration of
peritonitis (localized or diffuse) > 24 h)]
3 score
Risk factors
• Age>70 2 score
• Immunosuppression (chronic glucocorticoids,
immunosuppresant agents, chemotherapy, lymphatic
diseases, virus)
3 score
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